Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports

Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports

Introduction: The clinical relevance of Achromobacter xylosoxidans infection in cystic fibrosis (CF) remains controversial. This emerging agent in CF has been associated with increased lung inflammation, more frequent exacerbations and more severe lung disease. We describe a pair of CF siblings chro...

Full description

Bibliographic Details
Main Authors: Mônica Cássia Firmida, Elizabeth Andrade Marques, Robson Souza Leão, Rosana Helena Vicente Pereira, Elenice Rosa Aguiar Rodrigues, Rodolpho Mattos Albano, Tania Wrobel Folescu, Vagner Bernardo, Pedro Daltro, Domenico Capone, Agnaldo José Lopes
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Achromobacter spp.
Achromobacter xylosoxidans
Cystic fibrosis
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007116301885

Internet

http://www.sciencedirect.com/science/article/pii/S2213007116301885

Similar Items